Bill

Bill > S598


NJ S598

NJ S598
Requires health insurance coverage for certain neurological diseases.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill requires health insurance carriers (insurance companies, health, hospital, and medical service corporations, health maintenance organizations, and State and School Employees' Health Benefits Program contracts) to provide coverage for expenses incurred in the diagnosis and treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) that is prescribed or ordered by the treating physician. Coverage pursuant to the bill includes antibiotics, medication and behavioral therapies to manage neuropsychiatric symptoms, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy.

AI Summary

This bill mandates that various health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health benefits plans, health maintenance organizations, and state and school employee health plans, must cover the diagnosis and treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) when prescribed by a treating physician. This coverage is required to be provided to the same extent as for any other medical condition and includes treatments such as antibiotics, medications and behavioral therapies for neuropsychiatric symptoms, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy. The bill specifies that these provisions will apply to new or renewed insurance contracts and plans on or after the sixth month following its enactment.

Committee Categories

Business and Industry

Sponsors (5)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...